In a patient with fever, dry cough progressing to mildly productive cough, throat irritation, and night chills after three days of azithromycin without clinical improvement, which of the following antibiotics—doxycycline, azithromycin, amoxicillin, or cefuroxime—is appropriate?

Discontinue Azithromycin and Switch to Doxycycline

After three days of azithromycin without clinical improvement in a patient with fever, cough, throat irritation, and night chills, you should switch to doxycycline 100 mg twice daily. This represents treatment failure of the initial macrolide therapy, and doxycycline provides broader coverage for atypical pathogens while avoiding the adverse effects and resistance patterns associated with continued macrolide use.

Clinical Reasoning

Why Azithromycin Failed

The lack of clinical improvement after 3 days of azithromycin suggests either:

• Macrolide-resistant Streptococcus pneumoniae (highly prevalent, particularly in regions with >25% resistance) 1
• Atypical pathogens not responding to current therapy (Mycoplasma pneumoniae, Chlamydophila pneumoniae)
• Viral etiology (>90% of acute bronchitis cases) 1

Why Doxycycline is the Appropriate Switch

Doxycycline provides superior coverage in this clinical scenario:

• Effective against both typical and atypical respiratory pathogens 2, 3
• Recent high-quality evidence demonstrates doxycycline's effectiveness: A 2026 propensity-matched study of 108,017 CAP patients showed doxycycline had lower antibiotic switching rates (5.6% vs 7.8%) and fewer hospitalizations (2.9% vs 3.4%) compared to other antibiotics 3
• Comparable efficacy to azithromycin with better resistance profile: Network meta-analysis showed no significant differences between beta-lactam + doxycycline vs beta-lactam + azithromycin for mortality, ICU admission, or mechanical ventilation 4
• Avoids macrolide resistance issues and adverse effects (particularly QT prolongation and gastrointestinal disturbances) 1, 5

Why NOT the Other Options

Amoxicillin alone:

• Insufficient for atypical pathogens (Mycoplasma, Chlamydophila) that may be causing persistent symptoms
• Only appropriate if pneumonia is confirmed and typical bacterial etiology is suspected 1, 6

Cefuroxime alone:

• Similar limitations to amoxicillin—lacks atypical coverage
• More appropriate for confirmed pneumonia with typical bacterial pathogens 7, 8
• Higher cost without additional benefit in this clinical scenario 9

Continuing azithromycin:

• Already failed after 3 days
• Increased adverse events without additional benefit 1
• Macrolide resistance is a significant concern 10

Treatment Algorithm

Step 1: Assess for Pneumonia

Evaluate for these clinical criteria 1:

• Tachycardia (heart rate >100 bpm)
• Tachypnea (respiratory rate >24 breaths/min)
• Fever (oral temperature >38°C)
• Abnormal chest examination (rales, egophony, tactile fremitus)

If ALL four criteria are absent: Pneumonia is unlikely; this is likely acute bronchitis

Step 2: Management Based on Assessment

If acute bronchitis (no pneumonia):

• Switch to doxycycline 100 mg twice daily for 5-7 days 2, 3
• Consider symptomatic therapy: albuterol if wheezing present, dextromethorphan for cough 11, 1
• Reassess in 48-72 hours for clinical improvement

If pneumonia is suspected or confirmed:

• Switch to combination therapy: Amoxicillin 1g three times daily PLUS doxycycline 100 mg twice daily 6, 4
• Duration: 5-7 days for uncomplicated cases 7
• Consider chest X-ray if not already obtained

Step 3: Reassessment at 48-72 Hours

Clinical improvement should include:

• Defervescence or decreasing fever
• Reduced cough frequency and severity
• Improved constitutional symptoms
• No worsening dyspnea

If no improvement: Consider hospitalization, obtain chest imaging, and evaluate for complications or alternative diagnoses

Critical Pitfalls to Avoid

1. Don't continue ineffective azithromycin: Three days without improvement indicates treatment failure 7

2. Don't assume purulent sputum means bacterial infection: Purulence reflects inflammatory cells, not necessarily bacteria 1

3. Don't prescribe antibiotics for viral bronchitis: However, given 3 days of fever and lack of improvement on azithromycin, bacterial superinfection or atypical pathogen is more likely 11, 1

4. Don't use fluoroquinolones as first-line switch: Reserve for treatment failures or specific indications due to resistance concerns and adverse effects 2, 6

5. Don't overlook influenza: If during flu season, consider testing and antiviral therapy 6